In contrast, restoration of the promoter mutation to the wild-type sequence or depletion of GABPA in melanoma and glioblastoma cell lines enables silencing of the histone mark, suggesting that GABPA binding to TERT promoter is a key step to change the chromatin status [69]. The gene discussed is TERT; the disease is glioblastoma.